Other
RDEB
0
Pipeline Programs↗
0
Active Trials↗
0
Companies Involved↗
RDEB is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
2
clinical trials
Completed2 · 100%
Clinical Trials
Trial Activity
Rigosertib for RDEB-SCC
Completed·—·Phase 1/2·NCT03786237·2 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)